KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Income from Continuing Operations (2016 - 2025)

Thermo Fisher Scientific's Income from Continuing Operations history spans 17 years, with the latest figure at 2000000000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 11.67% year-over-year to 2000000000.0, compared with a TTM value of 6761000000.0 through Dec 2025, up 5.99%, and an annual FY2025 reading of 6761000000.0, up 5.97% over the prior year.
  • Income from Continuing Operations for Q4 2025 was 2000000000.0 at Thermo Fisher Scientific, up from 1619000000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 2337000000.0 in Q2 2021, with the low at 1308000000.0 in Q1 2024.
  • Average Income from Continuing Operations over 5 years is 1700900000.0, with a median of 1640000000.0 recorded in 2024.
  • Year-over-year, Income from Continuing Operations surged 196.57% in 2021 and then crashed 41.18% in 2023.
  • Tracing TMO's Income from Continuing Operations over 5 years: stood at 1659000000.0 in 2021, then fell by 3.32% to 1604000000.0 in 2022, then rose by 0.19% to 1607000000.0 in 2023, then rose by 11.45% to 1791000000.0 in 2024, then increased by 11.67% to 2000000000.0 in 2025.
  • Per Business Quant, the three most recent readings for TMO's Income from Continuing Operations are 2000000000.0 (Q4 2025), 1619000000.0 (Q3 2025), and 1617000000.0 (Q2 2025).